Stakeholders sometimes struggle to consider the range of activities on which ERNs and Industry could collaborate, besides the more traditional engagement around clinical trials, or more recently, partnering with multiple companies through the European Federation of Pharmaceutical Industries and Associations (EFPIA), in a large project via the Innovative Medicines Initiative, for instance. This resource builds upon material prepared for the comprehensive Together4RD Position Statement, to present a table listing a broad range of potential projects and activities which might be well-suited to ERN and Industry collaboration.
View this resource Bookmark this resource
Tool 8: Summary of areas or activities for potential ERN and Industry collaboration
Published by
European Reference NetworkIndustry collaborationRare DiseaseResearch and Drug Development
